View of First-year efficacy of 3.75 mg versus 11.25 mg depot leuprolide acetate and predictors of biochemical non-suppression in girls with central precocious puberty

Return to Article Details First-year efficacy of 3.75 mg versus 11.25 mg depot leuprolide acetate and predictors of biochemical non-suppression in girls with central precocious puberty Download Download PDF